Refractory Dissecting Cellulitis of the Scalp Treated With Adalimumab
October 2008 | Volume 7 | Issue 10 | Case Reports | 981 | Copyright © October 2008
Smita V. Sukhatme BS, Yolanda M. Lenzy MD MPH, Alice B. Gottlieb MD PhD
Dissecting cellulitis of the scalp (DCS) is a suppurative, neutrophillic dermatosis. Therapies typically provide short-term improvement and
include antibiotics, prednisone, and isotretinoin, as well as radiation, surgical excision, and laser ablation. The authors report the use of
the tumor necrosis factor (TNF) blocker, adalimumab, to successfully treat a 39-year-old male with a long-standing history of DCS.